Delivery Order SPE2DB24D2105-SPE2DB25FAPKF
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$84K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,555,991 units of Meloxicam 15 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $1,637.96 with a completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVJ26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,415.00 firm fixed-price delivery order is for 4,567,983,177 units of the medication Meloxicam 15 mg Tablet. The contract has an ultimate completion date of April 22, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This federal contract award, valued at $44,430.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,211,113 tablets of the medication Meloxicam 15 mg, with a firm fixed price and an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Meloxicam 15 mg tablets in 180-count bottles. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,774.69, and has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,478.52, is for the delivery of 4,567,528,404 units of the medication Meloxicam 15 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 11, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a large Indefinite Delivery...
This federal contract award is for the delivery of 4,566,281,392 units of 15 mg Meloxicam tablets over a period ending on October 31, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $39,305.93. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Meloxicam 7.5 mg tablets, a non-steroidal anti-inflammatory drug, with a ceiling value of $26,522.01. It is a firm fixed-price delivery order contract with a period of performance through September 23, 2024. AmerisourceBergen is a large supplier of pharmaceutical and medical products to various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 15 mg Meloxicam tablet units, a non-steroidal anti-inflammatory drug (NSAID), to support federal medical supply requirements. The contract has a firm fixed price of $10,626.54 and a completion date of May 20, 2025. This award is not set aside and is part of a larger Indefinite...
The Defense Logistics Agency awarded a $203,000 delivery order contract to Amerisourcebergen Drug Corporation to supply 1,000 tablets of 7.5 mg meloxicam. The contract has a firm fixed price and performance will take place in Conshohocken, Pennsylvania over a three-day period in early September 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor to fulfill this order for the analgesic medication in support of Defense Logistics...
The Defense Logistics Agency awarded a $61,540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 15 mg meloxicam. The delivery order was issued under an indefinite-delivery/indefinite-quantity multiple award contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by July 17, 2023 to support the Agency's medical supply needs. No set aside provisions or subcontractors were identified. The...